Breaking News

Back to ‘The Pitt’

February 22, 2026
avatar-torie-bosch
First Opinion editor

A few weeks ago, I asked how interested you are in more coverage of "The Pitt" on First Opinion. I heard from lots of you — thank you, it's always great to know I'm not just talking to myself here. The consensus was that you wanted to read about "The Pitt," but not necessarily weekly — only when someone had something important to say.

Well, here we are. On Friday, I published an op-ed by Allison Sesso, president and CEO of the nonprofit organization Undue Medical Debt, and Joe Sachs, an emergency physician, writer, and executive producer of the HBO Max series "The Pitt."

Sesso and Sachs wrote about Thursday's episode, which grapples with the ways that medical debt interferes with necessary care: "in the long history of medical TV shows, it's not often viewers see their own frustrations with deductibles, co-pays, and out-of-network charges reflected on the screen. Art is finally catching up with the long-brewing medical debt crisis."

The episode, and Sesso and Sachs' compelling essay, almost felt like a direct response to an op-ed First Opinion published last year, in which an emergency medicine resident wrote, "Here is where 'The Pitt' falls short. As we help patients on their worst days, we don't always consider the days that follow. We are not trained to weigh the financial burden placed on patients by our medical care. 'The Pitt' missed a chance to show the devastating financial consequences that can befall patients treated in the hospital."

My next goal: an op-ed or podcast interview with Ned Brower, an actor on "The Pitt" who also happens to have been an EMT and full-time pediatric emergency nurse.

I still haven't actually watched the show. I am steeling myself to binge it soon.

Recommendation of the week: "Summer House" is back on Bravo. The beautiful chuckleheads and their nonsense aren't even a guilty pleasure — just a straight-up pleasure.



JASON CONNOLLY/AFP via Getty Images

I took part in a 2012 psilocybin trial. What I'm seeing now horrifies me

For-profit companies are underplaying a key component of psychedelic therapy, the human guides that manage the setting and help interpret the experience.

By Erica Rex


My biggest GLP-1 ethical problem: patients who don't want to stop

I used to struggle with GLP-1 shortages. Now I'm facing the opposite problems: excess medication for some patients.

By Jody Dushay


AMA CEO: Deepfake doctors are a threat to public health

American Medical Association CEO John Whyte on the threat posed by AI scams using the faces and voices of real physicians.

By John Whyte


In this scene from "The Pitt," character Orlando Diaz speaks with resident physician Samira Mohan.
Warrick Page/HBO Max

On 'The Pitt,' art catches up with the medical debt crisis

Executive producer of 'The Pitt' and CEO of the Undue Medical Debt highlight a $220 billion medical debt crisis and the harm it inflicts on patients.

By Allison Sesso and Joe Sachs


STAT+ | Sometimes, it would be unethical not to use AI in medicine

Ignoring proven AI tools in medicine can constitute negligence. But so can blind adherence to algorithmic outputs.

By Morish Shah and Ami Bhatt


Same blood test, different results: Why isn't this common thyroid screening reliable?

Researchers have known for decades that different brands of lab machines produce different results. The fix is easy — but not enforced.

By Samantha Bonsack


Maddie Meyer/Getty Images

I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more

A former Moderna executive on the sudden, sharp decline in vaccine research in the U.S.

By Richard Hughes IV


When IV opioids are in short supply at the hospital, who gets pain relief?

Health care needs an ethical framework for determining who gets pain medication during drug shortages.

By Parker Crutchfield, Casey Chmura, and Abram Brummett


How public health saved the CDC Injury Center

The CDC's National Center for Injury Prevention and Control was almost eliminated. Then the public health community rallied.

By Sharon Gilmartin


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments